C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study)

Jung Hye Sung1, Jae Eun Lee, Tandaw E Samdarshi

  • 1aSchool of Health Sciences bRTRN Data Coordinating Center, Jackson State University cUniversity of Mississippi School of Medicine, Jackson, Mississippi, USA.

Insights

Systemic inflammation marker C-reactive protein (CRP) is linked to subclinical cardiovascular disease, specifically aortic valve calcification and peripheral arterial disease, in African-Americans.

Area of Science:

  • Cardiovascular Disease Research
  • Inflammation Biomarkers
  • Population Health Studies

Background:

  • Systemic inflammation is a potential early indicator of subclinical cardiovascular disease.
  • Previous research on inflammation and cardiovascular disease in African-Americans has yielded inconsistent findings.

Purpose of the Study:

  • To investigate the association between C-reactive protein (CRP) and subclinical cardiovascular disease in African-American adults.
  • To examine CRP's relationship with aortic valve calcification (AVC), carotid intima-medial thickness (IMT), and peripheral arterial disease (PAD).

Main Methods:

  • Analysis of data from African-American participants in the Jackson Heart Study.
  • Assessment of CRP levels in relation to AVC, carotid IMT, and PAD.
  • Statistical adjustments for various demographic, clinical, and lifestyle factors.

Main Results:

  • CRP showed a significant association with AVC (P=0.02) and PAD (P=0.04) in multivariable-adjusted models.
  • An association between CRP and carotid IMT was observed in age- and sex-adjusted models but not in multivariable models.
  • Prevalence of AVC was 5.1% and PAD was 6.7% in the study population.

Conclusions:

  • Significant associations were found between CRP and both AVC and PAD in a population-based cohort of African-Americans.
  • CRP may serve as a relevant biomarker for specific types of subclinical cardiovascular disease in this demographic.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620